Links provided here (scroll down) are to various research papers on the topics of AIDS, HEP-C, Cancer, Lymes Disease and are placed here as a result of a search for answers to questions concerning the efficacy of the use of the dried powder made from the Aloe Vera plant (see clinical trial below). The use of the Artemisia plant and specifically, its active ingredient Artemisinin was also simultaneously investigated as a possible companion or separate treatment of those diseases just mentioned.


No medical claims are intended or implied by this investigation.


Clinical Trial: The reader should also make note of the link to the results of a successful clinical trial conducted in several African locations by Plesion on 82 individual AIDS patients during the period 12/1/2011 to 9/30/2012. The clinical trial was conducted to prove the use of the aloe vera powder in capsule form on the AIDS community in several countries in multiple locations within those countries.


The reader is also free to draw his/her own conclusions after reading the research and if he/she so desires, can purchase the products for themselves by clicking the preferred links listed that enable them to buy the products on-line. At the present time, product availability is under commercial consideration and not available to the public (NOTE: as of 10/2012 -the products are not available through commercial outlets).


DISCLAIMER: Since Plesion is a US 501c3 not-for-profit humanitarian organization, any excess revenue over its cost derived from the sale or licensing of the products, Aspoir Rouge and Taste-n-See, will be used exclusively in the pursuit of its charitable activities.

Research Library for Hope Pharmacy project

Artemisia and moringa - and/or ARV drugs - the debate

The following discussion has been put together from several conversations in Musoma,Tanzania in June,2006. Those involved were Maike Ettling, German leader of the health division of the Diocese of Mara in the Africa Inland Church of Tanzania, Dr Peter Feleshi, doctor and state registered AIDS advisor, Philip Mateja, Evangelist and link person for anamed Tanzania, several HIV positive people (named person A, B, C etc we have their full names) and Dr Hans-Martin Hirt, pharmacist from Winnenden, Germany


Text Box: ABSTRACT: Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
		Thomas Efferth*
German Cancer Research Center, M070, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Received 29 March 2005; accepted 5 March 2005